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Objectives
Current findings in the biology of tumors and also new
tools for genome analysis have opened clinical perspec-
tives in oncology, generally termed as ‘personalized
medicine’. Pharmacogenomics examines how the bene-
fits and adverse effects of a drug vary among patients in
a target population by analyzing genomic profiles of
individual patients. Tailored treatment to a given patient
presenting with a given tumor is a must in these days.
Despite outstanding results in colorectal cancer, lung
cancer and melanoma, only a few predictive biomarkers
are currently justified in routine clinical practice. Unfor-
tunately so far there is still a gap between the growing
number of identified deregulated pathways and their
actual implementation as part of clinical routine.
Our current focus is on ATP-binding cassette (ABC)
transporters that contribute to development of resis-
tance to anticancer drugs via ATP-dependent drug
efflux [1,2]. The associations between the expression of
ABC transporters and outcome of carcinoma patients, e.
g. breast carcinoma patients, could elucidate some ques-
tion in pathophysiology of the disease and contribute to
new treatment strategies [3].
As long as endometriosis, characterized by the pre-
sence of endometrial tissue outside of the uterine cavity,
is one of the most common gynecologic disorders in
women of reproductive age and has many similarities
with cancer, we focus on this disease as well. Endome-
triosis is an inflammatory, estrogen-dependent condition
associated with pelvic pain and infertility. Decreased
quality of life is the most important predictor of direct
health care and total costs [4]. New interdisciplinary
research proposals in the field of endometriosis research
will contribute to its better understanding, earlier diag-
nosis and personalized treatment.
Another issue of our research is the oncofertility. As
long as chemotherapeutics, radiation, and surgery can
impact the future fertility of men, women, and children
with cancer the fertility impairment and loss due to
cancer or its treatment is a significant survivorship
consideration.
Suggested technologic approaches
Systems biology approaches are the must for an easier
implementation of personalized medicine at the bedside.
The new Biomedical centre of the Faculty of Medicine
in Pilsen is part of the Charles University. It houses a
multidisciplinary team of researchers engaged in colla-
borative research with partners across the globe. One of
the primary focuses of the centre is the identification of
predictive biomarkers of drug safety and efficacy with
the aim of translation from ‘bench-to-bedside’. The Cen-
tre is in a close vicinity of the University Hospital in Pil-
sen and emphasis the education of not only medical
students but also clinicians and scientists.
Expected impact if the project will succeed
New personalized medicine biomarkers, both prognostic
and predictive, will contribute to better classification of
patients into subgroups for treatment recommendation
and also to new personalized treatment of cancer and
endometriosis. Our aim is to support our young patients
and children also from the oncofertility point of view
and to save them hope for future fertility.
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